Steris PLC STE N

Morningstar Rating
MX$4,038.00 +63.00 (1.58%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

STE N is trading at a LOCK|!#&J& premium.
Price
MX$4,038.00
Fair Value
LOCK|%L.<%jqy%YF
Uncertainty
M>g
1-Star Price
LOCK|$K.Wc^x%LNP
5-Star Price
LOCK|$%.pNp<^G<
Economic Moat
LOCK|mxf$v
Capital Allocation
—

Trading Information

Previous Close Price
MX$3,975.00
Day Range
MX$4,038.00–4,038.00
52-Week Range
MX$3,824.43–4,038.00
Bid/Ask
MX$4,117.65 / MX$4,132.49
Shares Outstanding
97.50M
Market Cap
€393.71B
Volume/Avg
312 / 775

Key Statistics

Price/Earnings (Normalized)
21.54
Price/Sales
3.66
Dividend Yield (Trailing)
1.14%
Dividend Yield (Forward)
1.14%
Dividend Payment Schedule
Mar, Jun, Sep, Dec
Total Yield
2.58%

Company Profile

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Mid Core
Total Number of Employees
17,937

Competitors

Valuation

Metric
STE N
GETI B
MDT
Price/Earnings (Normalized)
21.5422.5816.86
Price/Book Value
3.122.232.43
Price/Sales
3.662.123.27
Price/Cash Flow
16.4913.7513.69
Price/Earnings
STE N
GETI B
MDT

Financial Strength

Metric
STE N
GETI B
MDT
Quick Ratio
1.170.721.29
Current Ratio
1.911.252.07
Interest Coverage
18.757.9110.12
Quick Ratio
STE N
GETI B
MDT

Profitability

Metric
STE N
GETI B
MDT
Return on Assets (Normalized)
8.10%6.11%8.31%
Return on Equity (Normalized)
12.06%11.50%15.59%
Return on Invested Capital (Normalized)
9.73%9.40%10.57%
Return on Assets
STE N
GETI B
MDT

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|D>#t@gLOCK|k>n!$179B
Medtronic PLC
MDT
LOCK|Q&k%vCdLOCK|<fyH$122B
Stryker Corp
SYK
LOCK|g>qQ#%#lLOCK|dv$118B
Boston Scientific Corp
BSX
LOCK|K#>zT<?LOCK|#gcNx$66B
Edwards Lifesciences Corp
EW
LOCK|%%&zG$xLOCK|@%Kf@$51B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|>@vMw^%LOCK|fP$32B
DexCom Inc
DXCM
LOCK|@lGS&YQYLOCK|Xb#S$29B
Koninklijke Philips NV ADR
PHG
LOCK|tnfLOCK|gb$26B
Steris PLC
STE
LOCK|cNZY%$!LOCK|tSGvF$23B
Zimmer Biomet Holdings Inc
ZBH
LOCK|?mX!M>@LOCK|c<$19B

Sponsor Center